文献速递帕金森病与运动障碍认知障碍与痴呆

明亮光照疗法治疗帕金森病抑郁的随机对照试验

Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
PubMed 文献 · Neurology · 2019-02-15

该双盲随机对照试验纳入83例帕金森病合并重性抑郁障碍患者,比较明亮光照疗法(±10,000 lux)与对照光(±200 lux)治疗3个月及6个月自然随访的疗效。结果显示两组HDRS评分均下降但组间无显著差异,BLT组主观睡眠质量改善更显著且唾液皮质醇总分泌量下降,对照组则上升。结论提示BLT在减轻抑郁症状方面不优于对照光。

要点

  • BLT在改善帕金森病合并抑郁症状方面不优于对照光。
  • BLT对主观睡眠质量的改善优于对照光,可能与皮质醇下降有关。
  • 两组抑郁情绪和主观睡眠均有改善,需注意安慰剂效应。

核心结论

  • 明亮光照疗法在减轻帕金森病合并重性抑郁障碍患者的抑郁症状方面不优于对照光装置(Class I证据)。

研究设计与样本

  • 双盲随机对照试验,纳入83例帕金森病合并重性抑郁障碍患者,随机接受BLT(±10,000 lux)或对照光(±200 lux)治疗3个月,随后6个月自然随访。

主要发现

  • 两组HDRS评分均下降,治疗结束时组间无显著差异。
  • BLT组主观睡眠质量改善优于对照组(B=0.32,SE=0.16,p=0.04)。
  • BLT组唾液皮质醇总分泌量下降,对照组上升(B=-8.11,SE=3.93,p=0.04)。

关键数值与推荐

  • 主要结局为汉密尔顿抑郁评定量表(HDRS)评分。
  • 次要结局包括客观和主观睡眠指标及唾液褪黑素和皮质醇浓度。

临床怎么用

  • BLT不作为帕金森病合并抑郁优于对照光的常规推荐,但可考虑用于改善主观睡眠质量。

局限性

  • 样本量83例,随访期间存在自然istic设计可能引入混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy of bright light therapy (BLT) in reducing depressive symptoms in patients with Parkinson disease (PD) and major depressive disorder (MDD) compared to a control light. METHODS: In this double-blind controlled trial, we randomized patients with PD and MDD to treatment with BLT (±10,000 lux) or a control light (±200 lux). Participants were treated for 3 months, followed by a 6-month naturalistic follow-up. The primary outcome of the study was the Hamilton Depression Rating Scale (HDRS) score. Secondary outcomes were objective and subjective sleep measures and salivary melatonin and cortisol concentrations. Assessments were repeated halfway, at the end of treatment, and 1, 3, and 6 months after treatment. Data were analyzed with a linear mixed-model analysis. RESULTS: We enrolled 83 participants. HDRS scores decreased in both groups without a significant between-group difference at the end of treatment. Subjective sleep quality improved in both groups, with a larger improvement in the BLT group (B [SE] = 0.32 [0.16], p = 0.04). Total salivary cortisol secretion decreased in the BLT group, while it increased in the control group (B [SE] = -8.11 [3.93], p = 0.04). CONCLUSION: BLT was not more effective in reducing depressive symptoms than a control light. Mood and subjective sleep improved in both groups. BLT was more effective in improving subjective sleep quality than control light, possibly through a BLT-induced decrease in cortisol levels. CLINICALTRIALSGOV IDENTIFIER: NCT01604876. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that BLT is not superior to a control light device in reducing depressive symptoms in patients with PD with MDD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rutten S, Vriend C, Smit JH, et al. Bright light therapy for depression in Parkinson disease: A randomized controlled trial. Neurology. 2019. PMID: 30770426. doi:10.1212/WNL.0000000000007090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。